Page last updated: 2024-08-23

torsemide and Absence Seizure

torsemide has been researched along with Absence Seizure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Lambert, D; Masereel, B; Pochet, L; Wouters, J1
Gramer, M; Hampel, P; Löscher, W; Römermann, K1
Gailus, B; Gericke, B; Hampel, P; Johne, M; Kaczmarek, E; Löscher, W; Römermann, K1
Delarge, J; Dogné, JM; Lambert, DM; Masereel, B; Poupaert, JH1

Other Studies

4 other study(ies) available for torsemide and Absence Seizure

ArticleYear
Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.
    Journal of medicinal chemistry, 1998, Aug-13, Volume: 41, Issue:17

    Topics: Animals; Anticonvulsants; Convulsants; Crystallography, X-Ray; Drug Design; Electroshock; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Conformation; Molecular Structure; Neurotoxins; Phenytoin; Seizures; Stereoisomerism; Structure-Activity Relationship; Thiourea

1998
The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain.
    Epilepsy & behavior : E&B, 2021, Volume: 114, Issue:Pt A

    Topics: Animals; Brain; Bumetanide; Endothelial Cells; Humans; Mice; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide

2021
Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
    Neuropharmacology, 2021, 03-01, Volume: 185

    Topics: Animals; Anticonvulsants; Bumetanide; Drug Therapy, Combination; Epilepsy; Female; Mice; Phenobarbital; Pilocarpine; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide; Treatment Outcome

2021
Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas.
    Epilepsia, 1997, Volume: 38, Issue:3

    Topics: Animals; Anticonvulsants; Diuretics; Epilepsy; Male; Mice; Neuroprotective Agents; Seizures; Sulfonamides; Sulfonylurea Compounds; Thiourea; Torsemide

1997